# TETRALOGIC PHARMACEUTICALS Corp

TETRALOGIC PHARMACEUTICALS Corp is a company headquartered in Paoli, NY, United States.

## Company overview

- **Legal name:** TETRALOGIC PHARMACEUTICALS Corp
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Paoli, NY, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001361248

## About

TETRALOGIC PHARMACEUTICALS Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001361248, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-03-16, it reported annual revenue of USD 0; net income of USD -49,724,054; total assets of USD 64,021,390 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$49.7M (USD -49,724,054)
- **Total assets:** $64.0M (USD 64,021,390)
- **Cash and equivalents:** $15.3M (USD 15,302,382)

### FY2014 (period ended 2014-12-31)

- **Net income:** -$36.0M (USD -35,958,979)
- **Total assets:** $118.3M (USD 118,291,046)
- **Cash and equivalents:** $13.1M (USD 13,073,137)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form SC 13G — filed 2017-08-04
- Form DEF 14A — filed 2016-12-01 — period 2016-12-29 — DEF 14A
- Form 8-K — filed 2016-11-22 — period 2016-11-18 — 8-K
- Form SC 13D — filed 2016-11-14 — SC 13D
- Form SC 13D — filed 2016-11-14 — SC 13D
- Form SC 13D — filed 2016-11-14 — SC 13D
- Form SC 13D — filed 2016-11-14 — TETRALOGIC PHARMACEUTICALS CORPORATION
- Form SC 13D — filed 2016-11-14 — DUNE ENERGY, INC.
- Form SC 13D — filed 2016-11-14 — SC 13D
- Form SC 13D — filed 2016-11-14 — SC 13D
- Form SC 13D — filed 2016-11-14 — SC 13D
- Form SC 13D — filed 2016-11-14 — SC 13D

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/tetralogic-pharmaceuticals-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology